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A recent meta-analysis of the efficacy of all types of
antidepressants in juvenile major depressive disorder
patients [1] urged that additional research be underta-
ken to clarify the basis of limited responses in adoles-
cents and children to antidepressant treatments
considered standard in the treatment of adult major
depressive disorder (MDD). Sprague-Dawley rats were
treated chronically with fluoxetine, imipramine, tranylcy-
promine or vehicle control. Total RNA was extracted
from brain cortices, cRNA was fragmented and hybri-
dised to Affymetrix Rat Genome 230 2.0 microarrays.
A total of 24 microarrays were analysed (ie, 6 biological
replicates in 4 treatment groups) and information on
the probesets of interest was obtained using different
websites. Taqman real-time qPCR methodology was
used to validate the transcripts identified from the
microarray data-analysis as the most significantly differ-
entially expressed in response to treatment with imipra-
mine or fluoxetine compared to vehicle. The relative
expression of each gene was also determined. In both
the imipramine- and fluoxetine-treated animals, expres-
sion of several genes was altered. These function in sig-
nal transduction (e.g., angiopoietin-like 4 protein),
protein metabolism (e.g., sulfotransferase family
1A, phenol-preferring, member 1), cell survival (e.g.,
response gene to complement 32, metallothionein 1a),
and nuclear functions (e.g., similar to Cat eye syndrome
critical region protein 2). Therefore, in the developing
rodent cortex, antidepressants alter the expression of
genes involved in signalling, cellular survival and protein
metabolism, involved in critical functions including neu-
ronal plasticity. These findings have implications for the
mechanisms of ADRs to antidepressants in children and
adolescents.
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